Liraglutide reduces body weight by upregulation of adenylate cyclase 3

OBJECTIVE: According to recent studies, adenylate cyclase 3 (AC3) is associated with obesity. Liraglutide reduces blood glucose levels and body weight (BW). We performed a 2 × 2 factorial experiment to study the relationships among AC3, liraglutide and obesity and to obtain a more comprehensive unde...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Z, Liang, Y, Xia, N, Lai, Y, Pan, H, Zhou, S, Jiang, F, He, Y
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5518799/
https://www.ncbi.nlm.nih.gov/pubmed/28481334
http://dx.doi.org/10.1038/nutd.2017.17

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5518799/
https://www.ncbi.nlm.nih.gov/pubmed/28481334
http://dx.doi.org/10.1038/nutd.2017.17

Ejemplares similares